The recently developed software (CONQUISTADOR) 
T here is no doubt that organized screening programs are effective in reducing the incidence and mortality of cervical carcinoma (CC), [1] [2] [3] and the Pap test (when properly done at all steps), remains at the moment the only screening test with established costeffectiveness. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] Like any other diagnostic procedure, however, Pap smear screening can be compromised at several steps. 4, 6, 9 Diagnostic reproducibility (measured by κ and weighted κ) and high accuracy are major issues in cytopathology, as discussed in several recent studies. 4, Indeed, a systematic monitoring of every step of the screening procedure is a fundamental prerequisite to make the program a success. [1] [2] [3] [4] [6] [7] [8] [9] In Italy, these issues have been seriously considered as part of measures taken toward improvement of ongoing regional screening programs. [22] [23] [24] [25] We recently developed 3 simple diagnostic variability indices (indices A, B and C) to provide a more easily interpretable measure of the consistency in cytodiagnosis of cervical intraepithelial neoplasia (CIN). 25 Until the recent development of new statistical software, CON-QUISTADOR, 30 these indices were calculated manually, which limited their usefulness in the continuous quality monitoring of cytology laboratories. This new software facilitates laboratory quality control (QC) procedures by calculating all the required QC indicators, as recently demonstrated. 30 To minimize the rate of false negative and false positive diagnoses, each cytopathology laboratory should actively pursue systematic intralaboratory QC programs and also participate in external interactive quality assurance schemes. Slide exchange and comparison of diagnosis is the core component of these interlaboratory QC measures, aimed at maintaining diagnostic standards, and establish consensus criteria through consensus opinion. 25 As part of the ongoing Latin American Screening (LAMS) study, 31 we designed an external interlaboratory QC program comparing reproducibility of cytologic diagnoses issued by the participating cytology laboratories in Brazil and Argentina. The aim was to assess the diagnostic agreement between different laboratories examining 2 basically different sets of slides (clear-cut and difficult ones) and to what extent this reproducibility can be improved by participation in this type of interlaboratory QC approach. The new CONQUISTADOR software was tested for the first time in true clinical samples and laboratories instead of a simulation study reported before. 30 For the availability of the free-of-charge software, contact conquistador@iss.it.
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The 80 slides were divided into 4 sets (A, B, C, and D) of 20 smears, each including in different proportions the 6 diagnostic categories of TBS 2001, except atypical squamous cells (ASCs) and atypical glandular cells (AGCs), to keep the sets including clear-cut cases only. These diagnostic categories are: inadequate smears, negative for intraepithelial lesions or malignancy (infection and reactive and reparative changes), low-grade squamous intraepithelial lesion (LSIL) or CIN 1 (associated or not with human papillomavirus (HPV), high-grade squamous intraepithelial lesion (HSIL) or CIN 2 (associated or not with HPV), HSIL or CIN 3 (associated or not with HPV), and invasive cancer (invasive squamous cancer, adenocarcinoma).
All slides were provided with a new label and a new identification code, wiping out the originals. A reporting form was designed, accompanied by a cover letter with detailed instructions for the participants on how to assess and report the slides. The only clinical information disclosed was the age of the patients. The database was built at National Center of Epidemiology, Surveillance and Promotion of Health, National Institute of Health (ISS), Rome, Italy, to record the responses from the 4 laboratories at various steps of the study.
As the second step, the fifth set (set E) of slides was compiled by the coordinators, using the same approach as in building up the first 4 sets (A-D). From the pool of 250 slides, 2 cytopathologists (M.B., M.A.) selected 20 cases, all being positive and also including borderline lesions, covering ASC, AGC, LSIL or CIN 1 (associated or not with HPV), HSIL or CIN 2 (associated or not with HPV), HSIL or CIN 3 (associated or not with HPV) and invasive cancer (invasive squamous cancer, adenocarcinoma). This selection was reviewed by the third examiner (K.S.), completing the process to reach the consensus diagnosis (used as the reference diagnosis). As the last step, slide set E 
Confidentiality
Strict anonymity was guaranteed for each participating laboratory. An identification code known by only the study coordinator (M.B.) was attributed to each participating laboratory to enable the recording of their responses completely anonymously.
Selection and Circulation of the Slides
The study design and methods of this study followed the strategy used in our previous study 25 of similar nature that was completed in Italy a few years ago. Instead of using a single set of slides as before, 25 we designed 5 sets (A-E) of slides, including both "clearcut" smears (as used in certification tests) (sets A-D) and an additional set (E) of "difficult smears," all being positive and also containing borderline lesions and glandular lesions. All slides used were of proven high technical quality.
Building Up the 5 Slide Sets
As the first step, all participating laboratories were asked to provide the study coordinators a series of conventional Pap smears, including all diagnostic categories of the 2001 Bethesda System (TBS 2001). Altogether, we received a pool of 250 such slides from 3 participating laboratories (laboratories 1, 2 and 3). In the coordinator's laboratory, 2 cytopathologists (M.B., M.A.) first examined the total pool of slides, selecting 80 smears with clear-cut diagnosis. These 80 slides were viewed by the third cytopathologist possessing the F.I.A.C. degree (K.S.), who suggested was circulated among the 4 laboratories, and instructions were given to complete the evaluation as for the sets A-D. In addition, they were asked to fill in a standardized form, containing the list of diagnoses and also a list of recommendations for management, as well as giving their judgment of the diagnostic difficulty of each individual case.
Data Analysis Using CONQUISTADOR Software
As recently reported in this journal, 30 ISS scientists and their collaborators developed a new statistical software (CONQUISTADOR), specifically designed to record cytology data in the routine laboratory and capable of calculating the necessary performance indicators (sensitivity, specificity, PPV, NPV), diagnostic accuracy indices, 25 as well as both normal and weighted κ values. This software is available in 2 versions: the basic version with intralaboratory procedures and an advanced version containing the interlaboratory procedures. Despite these different functions and purpose of use, the basic architecture and platform of these 2 versions is similar. 30 The basic functions of the CONQUISTADOR software have been previously described. 30 For the basic statistical analysis, all 100 initial diagnoses recorded from the 4 laboratories on the report forms were divided into 6 groups: 0 = diagnosis not made because of inadequate sampling; 1 = within normal limits, infection, and reactive and reparative changes; 2 = atypical squamous cells of undetermined significance (ASCUS) and atypical glandular cells of undetermined significance (AGC-US), LSIL or CIN 1 (associated or not with human papillomavirus (HPV); 3 = CIN 2 (associated or not with HPV); 4 = CIN 3 (associated or not with HPV); 5 = 3 and 4 taken together as HSIL; and 6 = invasive carcinoma (squamous cell carcinoma, adenocarcinoma). Sampling adequacy was limited to 2 categories: adequate and inadequate according to TBS 2001. Recommendations were grouped into 3 categories: 1 = no special recommendation; 2 = early repeated smear; and 3 = colposcopy or biopsy. The simple and weighted κ for individual laboratories, diagnostic categories, management recommendations and judgment of diagnostic difficulty were computed by the CONQUISTADOR software, using the algorithm by Fleiss and Cohen, including the 95% CI. 29, 30 In addition, the 3 diagnostic variability indices were calculated, as previously described 25 : index A concerns variability between CIN 1 plus HPV 
Results
All analyses were performed separately for the "clearcut" samples (slide sets A, B, C and D and the "difficult smears" (slide set E) and presented separately here as well. Table I summarizes the accuracy analysis of the slide sets A-D. For all laboratories together, sensitivity was 92.1% (95% CI 86.4-96.0) and specificity 85.6% (95% CI 78.4-91.1). The PPV was 87.2% and NPV was 91.1%. Seven cases were not registered as inadequate.
Agreement between individual laboratories in slide sets A-D is summarized in Table II , giving both simple and weighted κ values for these interlaboratory comparisons. The global summary of this agreement is given in Table III . Agreement is moderate using simple κ: κ = 0.50 (95% CI 0.44-0.56), but substantial (to almost perfect) using the weighted κ (κ w = 0.80) (95% CI 0.73-0.84).
The diagnostic variability indexes for individual slides in sets A-D are listed in Table IV . The indices A, B and C range from 1 (if all laboratories make the same diagnosis) to 0.5 (if half of the laboratories make 1 diagnosis and half the other 1) and computed using the following equations: A1 = 1 − 2(1 − A), B1 = 1 − 2(1 − B) and C1 = 1 − 2(1 − C). The mean of the index A was 0.90, index B 0.87 and index C (important variability) was 0.82. For these clear-cut sets, the mean A1 index was 0.80, the mean B1 index 0.74 and the mean C1 index was 0.64 (Table IV) . markedly lower compared with those calculated for the clear-cut cases in Table I . The PPV, however, was 100%. Agreement between individual laboratories in slide set E is summarized in Table VI , giving both simple and weighted κ values for these interlaboratory comparisons. The global summary of this agreement is given in Table VII . Agreement is moderate using simple κ: κ = 0.45 (95% CI 0.34-0.57) and does not markedly improve using the weighted κ (κ w = 0.53) (95% CI 0.36-0.69).
The diagnostic variability indexes for individual slides in set E are listed in Table VIII . The mean of the index A was 0.95, index B 1.00 and index C (important variability) was 0.80. For these difficult cases, the mean A1 index was 0.90, the mean B1 index 1.00 and the mean C1 index was 0.61 (Table VIII) .
Finally, all 5 sets were analyzed together. The performance indicators for the 5 sets are summarized in Table IX . Sensitivity was 85.7% (95% CI 80.3-90.1) and specificity 85.6% (95% CI 78.4-91.1). The interlaboratory reproducibility for all slide sets is shown in Table X , where simple κ is 0.51 (95% CI 0.46-0.56) and weighted κ = 0.80 (95% CI 0.76-0.85), which is the lower limit of almost perfect agreement. The diagnostic variability indices for the entire sets of slides are listed in Table XI , all exceeding 0.80, except CI index, which is 0.63.
Discussion
Issues related to QC in cytopathology laboratories have attracted considerable interest in the recent literature. 4, To minimize the rate of false negatives and false positives (the 2 fundamental diagnostic errors), it is necessary that cytopathology laboratories actively pursue different intralaboratory QC measures and also participate in external QC programs. In a previous paper, 25 we listed several features as essential elements in these interlaboratory QC measures. Slide exchange and diagnosis comparison is the core component of the interlaboratory QC schemes to maintain and check diagnostic approach and establish standard consensus criteria through consensus opinion. To be effective and adequate, this necessitates a setup of appropriate software for filing data and calculation of accuracy and reliability measures. Such calculations should include statistical analysis of the reliability and accuracy, using the reference diagnosis as baseline. 25, 30 Until recently, a single software program that could compute all the necessary indices, performance indicators and reproducibility tests was unavailable. To fill this gap, we recently developed new statistical software (CONQUISTADOR) that was originally tested for performance in a simulation study using virtual laboratories and virtual samples. 30 The program was developed in a standard Microsoft environment and operates with Windows '98 (Microsoft Inc., Redmond, Washington, U.S.A.) and later systems. It may be used on a single personal computer (workstation mode) and in a client and server environment. The software interfaces with Microsoft Office and, in particular, with Excel procedures (used for data import and export and printing) and with the Microsoft Access database, which the software accesses with standard Structured Query Language (SQL), via a fast, efficient Active Data Project (ADO) Provider. 30 The software also delivers full compatibility in the alternative use of the Microsoft SQL Server relational database, whose use, on the other hand, would be suitable only in the case of massive applications, which are mainly of the interlaboratory type. In addition to all performance indicators (SE, SP, PPV and NPV) and their 95% CI, this new software also calculates the recently introduced diagnostic accuracy indices, 25 as well as normal and weighted κ values. 29, 30 In the present study, this software was used, for the first time, in analysis of true clinical samples and using real laboratories as raters to test the interlaboratory reproducibility of conventional Pap smears. Indeed, diagnostic reproducibility and accuracy are the 2 major issues in cytopathology and can be addressed by a number of procedures and programs for quality assurance (QA). Practical and theoretical limitations, as well as benefits of external quality assurance (EQA) schemes for cervical cytology, have been extensively discussed in the recent literature. 4, [6] [7] [8] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] Several field studies have consistently shown that EQA settings improve the quality of diagnostic performance and enable participating laboratories to detect major deficiencies in specific areas of cervical cytology practice. [32] [33] [34] [35] [36] [37] [38] [39] [40] On one hand, data provided by performance evaluation systems are subject to potential bias. 32, 34, 36 According to EQA principles, any EQA system for cytology laboratories should assess the performance of each participant individually, as well as that of the laboratory as a whole. 37 Circulated slide sets among the laboratories is the core of the interlaboratory QC and quality improvement (QI), and it is the only method to evaluate interobserver and interlaboratory reproducibility. 17, 20, 23, 24, 39, 40 In the present study, we used slide sets at different levels of diagnostic difficulty: 4 sets of clear-cut cases (n = 80) and 1 set of difficult cases (n = 20). When the interlaboratory agreement in these 2 levels was compared, not unexpectedly, both regular κ and, particularly, weighted κ were markedly lower in the difficult cases slide set (set E), compared with the routine cases (sets A-D) (Tables III and VII) . This is not unexpected, because the former set included only positive cases, with all categories and borderline smears as well. The κ statistic is considered the most rigorous and reliable index, because it takes into account the extent of random agreement. It can be computed in 2 forms, simple κ and weighted κ. 27 The weighted κ, which can be used in cases in which the diagnostic categories can be ranked in an ordinal scale, takes into account not only the presence of disagreement but also its extent; that is, it gives more weight to a disagreement between CIN 1 and invasive cancer than between CIN 1 and CIN 2. 28, 29 Taking into consideration the diagnostic difficulty of set E, the weighted κ of 0.53, which implicates a moderate agreement, must be considered a good achievement (Table VII) . For the entire series of 5 slide sets, the weighted κ was 0.8 (Table X) , which is the lower limit of the almost perfect ranking, indicating excellent interlaboratory agreement among these 4 diagnostic laboratories. For these same reasons, the conventional performance indicators (SE, SP, PPV, and NPV) were also different in the 2 diagnostic difficulty categories (Tables I and V). In a meta-analysis of 62 studies concerning the performance of cytology toward histology, SE and SP ranged from 11% to 99% and 14% to 97%, respectively. 38 Overall, the performance of Pap smears in this study, as shown by the rate of false negatives and positives (SE 85.7% and SP 85.6%), was somewhat better than that reported in the literature. 38 The newly introduced diagnostic accuracy indices 25 were not remarkably different between the sets A-D and set E (Tables IV and VIII). As previously explained, these indices describe the ability to differentiate between the different diagnostic categories. 25 In this study, the ability to discriminate reliably between CIN 2 and CIN 3 was high (mean variability of index B was 0.89). Recently, Husain et al 36 found a crude agreement of 87% and a nonweighted κ of 0.79 in a comparison of the reporting patterns of 5 laboratories using 3 main diagnostic categories (benign, CIN, and malignant). 36 In our approach, using the diagnostic categories of TBS 2001, including ASC and AGC, a crude agreement of 0.67% was obtained among the 4 laboratories, with nonweighted κ of 0.45 (Table VII) . For these difficult cases, this reflects good diagnostic accuracy, which was not markedly better for routine cases (Table III) when nonweighted κ was used (0.51).
In evaluating the results of studies like this, it should be borne in mind that cytology and histology, like most diagnostic technologies, are subject to considerable intraobserver and interobserver variation. This is shown, for example, by the wide variation of the diagnostic categories of TBS among different laboratories. 25, 39 Alarmingly, interobserver agreement as low as 35% has been obtained among 5 experienced cytopathologists assessing 20 smears using TBS. 19 Compared with that, the results of the present exercise are significantly better, however. For the entire set of 100 slides (including both the clear-cut and difficult cases), the raw agreement was 67%, with regular κ = 0.51 and weighted κ = 0.80. The latter, in particular, indicates that the interlaboratory agreement among these 4 diagnostic laboratories is substantial (in fact, varying from substantial to almost perfect).
In conclusion the present study shows that it is possible to achieve high interlaboratory reproducibility in the assessment of slide sets similarly as is regularly used in aptitude or proficiency tests, 41 if TBS 2001 criteria are strictly followed. Our results also indicate
